载脂蛋白E拟肽在颅脑损伤中的应用进展
《创伤外科杂志》[ISSN:/CN:]
- 期数:
- 2013年15卷06期
- 页码:
- 553-556
- 栏目:
- 综述
- 出版日期:
- 2013-12-10
文章信息/Info
- Title:
- Treatment progress of apoE mimetic peptides in traumatic brain injury
- Author(s):
- LIU Jieshi; JIANG Yong
- epartment of Neurosurgery,Hospital of Luzhou Medical College,Luzhou 646000,China
- 分类号:
- R 651.15
- DOI:
- -
- 文献标识码:
- A
- 摘要:
- 【摘要】载脂蛋白E(apoE)拟态是来源于apoE受体结合域的模拟肽，不仅能透过血脑屏障，还保留了全蛋白的大部分功能。近期研究表明其在颅脑损伤的神经保护及治疗中发挥着重要的作用。本文综合相关文献，对apoE拟态在颅脑损伤治疗中的研究进行综述，以进一步拓宽apoE拟态在将来神经系统疾病治疗的研究。
参考文献/References
［1］Huang Y.Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases［J］.Curr Opin Lipidol,2010,2(4)：337-345．
［2］Sivashanmugam A,Wang J.A unified scheme for initiation and conformational adaptation of human apolipoprotein E N-terminal domain upon lipoprotein binding and for receptor binding activity［J］.J Biol Chem,2009,284(21):14657-14666.
［3］Huang Y,Weisgraber KH,Mucke L,et al.Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease［J］.J Mol Neurosci,2004,23（3）:189-204.
［4］Xu Q,Bernardo A,Walker D,et al.Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus［J］.J Neurosci,2006,26（19）:4985-4994.
［5］Rall SC Jr,Weisgraber KH,Mahley RW.Human apolipoprotein E.The complete amino acid sequence［J］.J Biol Chem,1982,257（8）:4171-4178 .
［6］Dong LM,Weisgraber KH.Human apolipoprotein E4 domain interaction.Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins［J］.J Biol Chem,1996,271（32）:19053-19057 .
［7］Mahley RW,Weisgraber KH,Huang Y.Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS［J］.J Lipid Res,2009,50（S）:S183-188.
［8］Guttman M,Prieto JH,Handel TM,et al.Structure of the minimal interface between ApoE and LRP［J］.J Mol Biol,2010,398(2):306-319.
［9］Laskowitz DT,McKenna SE,Song P,et al.COG1410,a novel apolipeprotein E-based peptide,improves functional recovery in a murine model of trumatic brain injury［J］.Neurotrauma,2007,24(7):1093-1107．
［10］Jiang Y,Sun X,Xia Y,et al.Effect of APOE polymorphisms on early responses to traumatic brain injury［J］.Neurosci Lett,2006,408(2):155-158.
［11］Wu HT,Zhang XD,Su H,et al.Association of apolipoprotein E polymorphisms with cerebral vasospasm after spontaneous subarachnoid hemorrhage［J］.Acta Neurochir Suppl,2011,110(Pt1):141-144.
［12］ Gu L,Su L,Chen Q,et al.Association between the apolipoprotein E gene polymorphism and ischemic stroke in Chinese populations: New data and meta-analysis［J］.Exp Ther Med,2013,5(3):853-859.
［13］Sadigh-Eteghad S,Talebi M,Farhoudi M.Association of apolipoprotein E epsilon 4 allele with sporadic late onset Alzheimer`s disease：a meta-analysis［J］.Neurosciences(Riyadh),2012,17(4):321-326.
［14］Rafiei M,Zarif YM,Sheikholeslami S,et al.Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis［J］.J Neurol Sci,2012,320(1-2):22-25.
［15］Morley JF,Xie SX,Hurtig HI,et al.Genetic influences on cognitive decline in Parkinson's disease［J］.Mov Disord, 2012,27(4):512-518.
［16］Buttini M,Akeefe H,Lin C,et al.Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease［J］.Neuroscience,2000,97(2):207-210.
［17］Xu PT,Li YJ,Qin XJ,et al.A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease［J］.Mol Cell Neurosci,2007,36(3):313-331.
［18］LaDu MJ,Shah JA,Reardon CA,et al.Apolipoprotein E and apolipoprotein E receptor modulate A beta-induced gliai neuminflammatory responses［J］.Neurochem Int,2001,39(5-6):427-434．
［19］Lynch JR,Tang W,Wang H,et al.APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response［J］.J Biol Chem,2003,278(49):48529-48533．
［20］Christensen DJ,Ohkubo N,Oddo J,et al.Apolipoprotein E and peptide mimetics modulate inflammation by binding the SET protein and activating protein phosphatase 2A［J］.J Immunol,2011,186(4):2535-2542．
［21］Li FQ,Sempowski GD,McKenna SE,et al.Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis［J］.J Pharmacol Exp Ther,2006,318(3): 956-965．
［22］Mullick AE,Powers AF,Kota RS,et al.Apolipoprotein E3-and nitric oxide-dependent modulation of endothelial cell inflammatory responses［J］.Arterioscler Thromb Vasc Biol,2007,27(2):339-345．
［23］Zhu Y,Kodvawala A,Hui DY.Apolipoprotein E inhibits toll-like receptor (TLR)-3- and TLR-4-mediated macrophage activation through distinct mechanisms［J］.Biochem J,2010,428(1):47-54.
［24］SirIgh K,Chaturvedi R,Asim M,et al.The apolipoprotein E-mimetic peptide COG1 12 inhibits the inflammatory response to Citrobacter mdentium in colonic epithelial cells by preventing NF-kappaB activation［J］.J Biol Chem,2008,283(24):16752-16761．
［25］Singh K,Chaturvedi R,Barry DP,et al.The apolipoprotein E-mimetic peptide COG112 inhibits NF-kappaB signaling, proinflammatory cytokine expression, and disease activity in murine models of colitis［J］.J Biol Chem,2011,286(5):3839-3850.
［26］Christensen DJ,Ohkubo N,Oddo J,et al.Apolipoprotein E and peptide mimetics modulate inflammation by binding the SET protein and activating protein phosphatase 2A［J］.J Immunol,2011,186(4): 2535-2542.
［27］Gaultier A,Wu X,Le MN,et al.Low-density lipoprotein receptor related protein 1 is an essential receptor for myelin phagocytosis［J］．J Cell Sci,2009,122(8):1155-1162.
［28］Hayashi H,Campenot RB,Vance DE,et al.Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein-1［J］.J Neurosci,2007,27(8):1933-1941.
［29］Sheng Z,Prorok M,Brown BE,et al.N-Methyl-D-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on low density lipoprotein receptor-associated prote［J］.Neuropharmacology,2008,55(2):204-214.
［30］Vitek MP,Christensen DJ,Wilcock D,et al.APOE-mimetic peptides reduce behavioral deficits,plaques and tangles in alzheimer's disease transgenics［J］.Neurodegener Dis,2012,10(1-4):122-126.
［31］Ghosal K,Stathopoulos A,Thomas D,et al.The apolipoprotein-E-mimetic COG112 protects amyloid precursor protein intracellular domain-overexpressing animals from alzheimer's disease-like pathological features［J］.Neurodegener Dis,2012,Epub.
［32］Datta G,Chaddha M,Handattu SP,et al.ApoE mimetic peptide reduces plasma lipid hydroperoxide content with a concomitant increase in HDL paraoxonase activity［J］.Adv Exp Med Biol,2010,660（4）:1-4.
［33］Zhao W,Du F,Zhang M,et al.A new recombinant human apolipoprotein E mimetic peptide with high-density lipoprotein binding and function enhancing activity［J］.Exp Biol Med,2011,236(12):1468-1476.
［34］Sharifov OF,Nayyar G,Garber DW,et al.Apolipoprotein E mimetics and cholesterol-lowering properties［J］.Am J Cardiovasc Drugs,2011,11(6):371-381.
［35］Hoane MR,Pierce JL,Holland MA,et al.The novel apolipepmtein E-based peptide COG1410 improves sensorimotor performance and reduces injury magnitude following conical contusion injury［J］.Nerurotrauma,2007,24(7):1108-1118．
［36］Kaufman NA,Beare JE,Tan AA,et al.COG1410, an apolipoprotein E-based peptide,improves cognitive performance and reduces cortical loss following moderate fluid percussion injury in the rat［J］.Behav Brain Res,2010,214(2):395-401.
［37］Jiang Y,Brody DL.Administration of COG1410 reduces axonal amyloid precursor protein immunoreactivity and microglial activation after controlled cortical impact in mice［J］.J Neurotrauma,2012,29(13):2332-2341.
［38］Laskowitz DT,Lei B,Dawson HN,et al.The a poE-mimetic peptide,COG1410,improves functional recovery in a murine model of intracerebral hemorrhage［J］.Neurocrit Care,2012,16(2):316-326.
［39］Wang H,Durham L,Dawson H,et al.An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction［J］.Neuroscience,2007,144(4):1324-1333.
［40］Laskowitz DT,Song P,Wang H,et al.Traumatic brain injury exacerbates neurodegenerative pathology:improvement with an apolipoprotein E-based therapeutic［J］.J Neurotrauma,2010,27(11):1983-1995.
［41］James ML,Sullivan PM,Lascola CD,et al.Pharmacogenomic effects of apolipoprotein E on intracerebral hemorrhage［J］.Stroke,2009,40(2):632-639.
备注/Memo
- 备注/Memo:
- 基金项目：国家自然科学青年基金项目（81000528）；新世纪优秀人才支持计划（NCET-12-1057）；四川省科学技术厅科学研究项目（2009JY0126）；四川省卫生厅科学研究项目（090217）；四川省教育厅青年基金项目（08zb049）
